Bath & Body Works, Inc. Declares Dividend of $0.20 (NYSE:BBWI)

Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) announced a dividend on Friday, May 13th, Fidelity reports. Shareholders of record on Friday, June 3rd will be paid a dividend of 0.20 per share on Friday, June 17th. The ex-dividend date is Thursday, June 2nd.

Shares of NYSE:BBWI opened at $42.45 on Tuesday. Bath & Body Works has a 12-month low of $35.46 and a 12-month high of $82.00. The business’s fifty day simple moving average is $48.92 and its 200-day simple moving average is $57.07. The company has a market capitalization of $10.12 billion, a PE ratio of 9.25, a P/E/G ratio of 1.28 and a beta of 1.56.

Bath & Body Works (NYSE:BBWI – Get Rating) last announced its quarterly earnings results on Wednesday, May 18th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.53 by $0.11. Bath & Body Works had a negative return on equity of 83.19% and a net margin of 15.41%. Sell-side analysts forecast that Bath & Body Works will post 4.01 EPS for the current fiscal year.

Several brokerages recently weighed in on BBWI. B. Riley dropped their target price on Bath & Body Works from $76.00 to $67.00 and set a “buy” rating on the stock in a research note on Friday, May 20th. The Goldman Sachs Group dropped their price target on Bath & Body Works from $85.00 to $61.00 and set a “buy” rating on the stock in a research note on Friday, May 20th. Zacks Investment Research downgraded Bath & Body Works from a “hold” rating to a “sell” rating in a research note on Wednesday, May 25th. Citigroup dropped their price target on Bath & Body Works from $87.00 to $54.00 and set a “buy” rating on the stock in a research note on Monday, May 23rd. Finally, Morgan Stanley dropped their price target on Bath & Body Works from $95.00 to $64.00 and set an “overweight” rating on the stock in a research note on Friday, May 20th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seventeen have assigned a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Buy” and a consensus price target of $66.20.

In other Bath & Body Works news, CFO Wendy C. Arlin sold 6,000 shares of the firm’s stock in a transaction on Tuesday, April 19th. The stock was sold at an average price of $55.00, for a total value of $330,000.00. Following the sale, the chief financial officer now directly owns 98,888 shares in the company, valued at $5,438,840. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.37% of the stock is currently owned by company insiders.

Several hedge funds have recently modified their holdings of BBWI. Renaissance Technologies LLC purchased a new position in shares of Bath & Body Works during the first quarter worth about $84,383,000. Arrowstreet Capital Limited Partnership grew its holdings in shares of Bath & Body Works by 34.5% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,830,984 shares of the company’s stock worth $135,321,000 after buying an additional 726,384 shares during the last quarter. Eaton Vance Management grew its holdings in shares of Bath & Body Works by 95.8% during the first quarter. Eaton Vance Management now owns 1,112,568 shares of the company’s stock worth $53,181,000 after buying an additional 544,210 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Bath & Body Works by 26.3% during the first quarter. Invesco Ltd. now owns 2,584,966 shares of the company’s stock worth $123,561,000 after buying an additional 538,353 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new stake in Bath & Body Works in the 1st quarter valued at approximately $18,662,000. 97.11% of the stock is currently owned by institutional investors.

About Bath & Body Works (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Recommended Stories